<--- Back to Details
First PageDocument Content
Macrolides / Health / Type 1 hypersensitivity / Tacrolimus / Pimecrolimus / Eczema / Atopy / Atopic dermatitis / Topical steroid / Medicine / Immunosuppressants / Pharmacology
Date: 2003-11-25 15:49:19
Macrolides
Health
Type 1 hypersensitivity
Tacrolimus
Pimecrolimus
Eczema
Atopy
Atopic dermatitis
Topical steroid
Medicine
Immunosuppressants
Pharmacology

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 579,50 KB

Share Document on Facebook

Similar Documents

Clinical medicine / Medicine / Cancer / Antineoplastic drugs / Cancer treatments / Signal transduction / Breast cancer / Macrolides / Eribulin / Halichondrin B / MTOR inhibitors / Eisai

EISAI AND PIQUR SIGN LANDMARK COLLABORATION AGREEMENT TO INVESTIGATE HALAVEN® (ERIBULIN) AND PQR309 IN HARD TO TREAT FORM OF BREAST CANCER Agreement will see eribulin used in combination with novel PI3K/mTOR inhibitor i

DocID: 1rhhk - View Document

Immunosuppressants / Macrolides / Medicine / Clinical medicine / Sirolimus / Chemistry / Everolimus / Hives / Tacrolimus / Mechanistic target of rapamycin

The brain sirolimus pills. Note: Any medical information published on this computer for up to 3 capsules of Xanax. The brain. To view content sources and attributions, refer to the increase in the past 14 days. Wenn Sie

DocID: 1qxur - View Document

Medicine / Clinical medicine / Health / Macrolides / Immunosuppressants / Santen Pharmaceutical / Sirolimus / Central Drugs Standard Control Organization / Intravitreal administration / Mechanistic target of rapamycin

Microsoft Word - 20160704_Opsiria_India

DocID: 1q3TJ - View Document

Immunosuppressants / Pharmacokinetics / Macrolides / Tacrolimus

Beilage 1: Arzneimittelmonographien

DocID: 1oXt7 - View Document

Medicine / Clinical medicine / Immunology / Immunosuppressants / Macrolides / Signal transduction / Cancer treatments / Immunosuppressive drug / Sirolimus / Calcineurin / Tacrolimus / Cytokine

Microsoft PowerPoint - PhilNat-ClinImmunmodulation2016 handout [Kompatibilitätsmodus]

DocID: 1ogX3 - View Document